SDF-1 and its receptor in the ventricles of rat with monocrotaline-induced pulmonary hypertension

Veteskova, J.; Obsivan, M.; Kmecova, Z.; Radik, M.; Srankova, J.; Malikova, E.; Klimas, J.; Krenek, P.

doi:10.2478/afpuc-2018-0004

Abstract

Aim: Chemokine stromal cell derived factor-1 (SDF-1) plays an important role in many processes such as apoptosis, proliferation, migration and angiogenesis, and these effects are mediated mostly by the receptor CXCR4. The aim of this study was to determine the expression of SDF-1 and CXCR4 in the ventricles of rats with monocrotaline-induced pulmonary hypertension.

Methods: 10–12 weeks old male Wistar rats were injected with monocrotaline (s. c., 60mg/kg; MON) or vehicle (CON). Rats were sacrificed 1 week (1W-MON, 1W-CON), 2 weeks (2W-MON, 2W-CON) and 4 weeks after monocrotaline administration (4W-MON, 4W-CON). Gene expression of SDF-1 and CXCR4 was determined by qRT-PCR.

Results: We observed a decrease in the SDF-1 expression on mRNA level in the right ventricle in 2W-MON and 4W-MON rats without any changes in the left ventricles and a decrease in CXCR4 expression in 1W-MON in both ventricles with an increase of CXCR4 expression in 4W-MON in the left ventricle (*P ˂ 0.05).

Conclusion: SDF-1/CXCR4 axis is affected in both ventricles of rats with monocrotaline model of pulmonary hypertension.

References

[1] Bleul CC, Fuhlbrigge RC, Casasnovas JM, Aiuti A, Springer TA. A highly efficacious lymphocyte chemoattractant, stromal cellderived factor 1 (SDF-1). J Exp Med. 1996;184(3):1101-9.10.1084/jem.184.3.110121927989064327
Search in Google Scholar Back to article
[2] Bogaard HJ, Abe K, Vonk Noordegraaf A, Voelkel NF. The right ventricle under pressure: cellular and molecular mechanisms of right-heart failure in pulmonary hypertension. Chest. 2009;135(3):794-804.10.1378/chest.08-049219265089
Search in Google Scholar Back to article
[3] Burke DL, Frid MG, Kunrath CL et al. Sustained hypoxia promotes the development of a pulmonary artery-specific chronic inflammatory microenvironment. Am J Physiol Lung Cell Mol Physiol. 2009;297(2):L238-50.10.1152/ajplung.90591.2008274280019465514
Search in Google Scholar Back to article
[4] Doka G, Malikova E, Galkova K et al. Downregulation of myogenic microRNAs in sub-chronic but not in sub-acute model of daunorubicin-induced cardiomyopathy. Mol Cell Biochem. 2017;432(1-2):79-89.10.1007/s11010-017-2999-828303410
Search in Google Scholar Back to article
[5] Gambaryan N, Perros F, Montani D et al. Targeting of c-kit+ haematopoietic progenitor cells prevents hypoxic pulmonary hypertension. Eur Respir J. 2011;37(6):1392-9.10.1183/09031936.0004571020884740
Search in Google Scholar Back to article
[6] Galiè N, Humbert M, Vachiery JL et al. 2015 ESC/ERS Guidelines for the Diagnosis and Treatment of Pulmonary Hypertension. Rev Esp Cardiol (Engl Ed). 2016;69(2):177.10.1016/j.recesp.2016.01.002
Search in Google Scholar Back to article
[7] Gomez-Arroyo JG, Farkas L, Alhussaini AA et al. The monocrotaline model of pulmonary hypertension in perspective. Am J Physiol Lung Cell Mol Physiol. 2012;302(4):L363-9.10.1152/ajplung.00212.201121964406
Search in Google Scholar Back to article
[8] Hoeper MM, Bogaard HJ, Condliffe R et al. Definitions and diagnosis of pulmonary hypertension. J Am Coll Cardiol. 2013;62(25 Suppl):D42-50.10.1016/j.jacc.2013.10.03224355641
Search in Google Scholar Back to article
[9] Jackson EK, Zhang Y, Gillespie DD, Zhu X, Cheng D, Jackson TC. SDF-1α (Stromal Cell-Derived Factor 1α) Induces Cardiac Fibroblasts, Renal Microvascular Smooth Muscle Cells, and Glomerular Mesangial Cells to Proliferate, Cause Hypertrophy, and Produce Collagen. J Am Heart Assoc. 2017;6(11).10.1161/JAHA.117.007253572179429114002
Search in Google Scholar Back to article
[10] Lai YC, Potoka KC, Champion HC, Mora AL, Gladwin MT. Pulmonary arterial hypertension: the clinical syndrome. Circ Res. 2014;115(1):115-30.10.1161/CIRCRESAHA.115.301146409668624951762
Search in Google Scholar Back to article
[11] McCullagh BN, Costello CM, Li L et al. Elevated plasma CXCL12α is associated with a poorer prognosis in pulmonary arterial hypertension. PLoS One. 2015;10(4):e0123709.10.1371/journal.pone.0123709439183325856504
Search in Google Scholar Back to article
[12] Schioppa T, Uranchimeg B, Saccani A et al. Regulation of the chemokine receptor CXCR4 by hypoxia. J Exp Med. 2003;198(9):1391-402.10.1084/jem.20030267219424814597738
Search in Google Scholar Back to article
[13] Shao S, Cai W, Sheng J, Yin L. Role of SDF-1 and Wnt signaling pathway in the myocardial fibrosis of hypertensive rats. Am J Transl Res. 2015;7(8):1345-56.
Search in Google Scholar Back to article
[14] Srankova J, Doka G, Pivackova L et al. Daunorubicin Down-Regulates the Expression of Stem Cell Markers and Factors Involved in Stem Cell Migration and Homing in Rat Heart in Subchronic but not Acute Cardiomyopathy. Basic Clin Pharmacol Toxicol. 2016;119(5):443-452.10.1111/bcpt.1260627090888
Search in Google Scholar Back to article
[15] Sutendra G, Dromparis P, Paulin R et al. A metabolic remodeling in right ventricular hypertrophy is associated with decreased angiogenesis and a transition from a compensated to a decompensated state in pulmonary hypertension. J Mol Med (Berl). 2013;91(11):1315-27.10.1007/s00109-013-1059-423846254
Search in Google Scholar Back to article
[16] Yu L, Hales CA. Effect of chemokine receptor CXCR4 on hypoxiainduced pulmonary hypertension and vascular remodeling in rats. Respir Res. 2011;12:21.10.1186/1465-9921-12-21304239821294880
Search in Google Scholar Back to article
[17] Wang ER, Jarrah AA, Benard L et al. Deletion of CXCR4 in cardiomyocytes exacerbates cardiac dysfunction following isoproterenol administration. Gene Ther. 2014;21(5):496-506.10.1038/gt.2014.23401611224646609
Search in Google Scholar Back to article

SDF-1 and its receptor in the ventricles of rat with monocrotaline-induced pulmonary hypertension

Abstract

Paradigm

My account